title: Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia.
authors.forename: L
authors.initials: L
authors.lastname: Catani
authors.forename: R
authors.initials: R
authors.lastname: Zini
authors.forename: D
authors.initials: D
authors.lastname: Sollazzo
authors.forename: E
authors.initials: E
authors.lastname: Ottaviani
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
authors.forename: S
authors.initials: S
authors.lastname: Ferrari
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
authors.forename: N
authors.initials: N
authors.lastname: Vianelli
authors.forename: R M
authors.initials: RM
authors.lastname: Lemoli
authors.forename: R
authors.initials: R
authors.lastname: Manfredini
mesh_terms: D000328:Adult; D000368:Aged; D018952:Antigens, CD34 / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D013234:Stem Cells / Q000378:metabolism*; D013920:Thrombocythemia, Essential / Q000235:genetics* / Q000378:metabolism / Q000473:pathology
chemical_list: D018952:Antigens, CD34; D014408:Biomarkers, Tumor; C507924:JAK2 protein, human; D053614:Janus Kinase 2